The Biological Role of Fibrinolysis

  • J. F. Davidson
  • Isobel D. Walker
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 164)


Fibrinolysis is a basic defence mechanism of the organism designed to control the deposition of fibrin in the vascular system and elsewhere. This fibrin polymer deposition is regulated by the fibrinolytic system which acts on the insoluble protein and by splitting a limited number of peptide bonds renders it soluble.


Tranexamic Acid Fibrinolytic System Fibrinolytic Therapy Important Biological Role Human Plasminogen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    D. Collen, B. Wiman, The fast acting plasmin inhibitor of human plasma: In: Davidson, J.F., Cepelak, V., Samama, M.M., Desnoyers, P.C. Eds.: Progress in chemical fibrinolysis and thrombolysis, Vol. IV, Edinburgh: Churchill Livingstone, 1979: 11–19.Google Scholar
  2. 2.
    T. Astrup, Fibrinolysis: an overview: In Davidson, J.F., Rowan, R.M., Samama, M.M., Desnoyers, P.C. Eds.: Progress in chemical fibrinolysis and thrombolysis; Vol. IV, New York: Raven Press, 1978: 1–57.Google Scholar
  3. 3.
    K. Koie, T. Kamiya, K. Ogata, J. Takamatsu, M. Kohakura, α2 Plasmin — inhibitor deficiency Miyasato disease. Lancet 2: 1334–1336 (1978).PubMedCrossRefGoogle Scholar
  4. 4.
    N. Aoki, H. Saito, T. Kamiya, K. Koie, Y. Sakata, M. Kohakura, Congenital deficiency of α2-Plasmin inhibitor associated with severe haemorrhagic tendency. J. Clin. Invest. 63:877–884. (1979).PubMedCrossRefGoogle Scholar
  5. 5.
    C. Kluft, E. Vellegua, E.J.P. Brommer, Homozygous α2-antiplasmin deficiency. Lancet 2: 206 (1979).PubMedCrossRefGoogle Scholar
  6. 6.
    N. Aoki, M. Moroi, Y. Sakata, N. Yoshida, M. Matsuda, Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. J. Clin. Invest. 61: 1186–1195 (1979).CrossRefGoogle Scholar
  7. 7.
    R.C. Wohl, L. Summaria, K.C. Robbins, Physiological activation of the human fibrinolytic system. Isolation and characterisation of human plasminogen variants, Chicago I and Chicago II. J. Biol. Chem. 254: 9063–9069 (1979).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • J. F. Davidson
    • 1
  • Isobel D. Walker
    • 1
  1. 1.Department of HaematologyGlasgow Royal InfirmaryGlasgowUK

Personalised recommendations